Crinone

Crinone

progesterone

Manufacturer:

PT. Merck Tbk
Concise Prescribing Info
Contents
Progesterone
Indications/Uses
Infertility due to inadequate luteal phase. For use during in vitro fertilization (IVF), where infertility is mainly due to tubal, idiopathic or endometriosis linked sterility associated w/ normal ovulatory cycles.
Dosage/Direction for Use
Infertility due to inadequate luteal phase 1 application daily, starting after documented ovulation or arbitrarily on the 18th-21st day of cycle. When used during IVF, daily application of 8% gel should be continued for 1 mth if there is lab evidence of pregnancy. Recommended duration of therapy: 12 wk.
Contraindications
Undiagnosed uterine bleeding; porphyria. Lactation.
Special Precautions
Severe hepatic insufficiency. Not to be used concurrently w/ other intravag therapy.
Adverse Reactions
Drug Interactions
Should not be used concurrently w/ other local intravag therapy.
ATC Classification
G03DA04 - progesterone ; Belongs to the class of pregnen (4) derivative progestogens.
Presentation/Packing
Form
Crinone vag gel 8%
Packing/Price
90 mg x 15 × 1's (Rp1,126,400/boks)
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in